FDA Gains ‘Continuity’ as Mikhail, Davis Named Permanent CBER, CDER Leaders

Four Officials Who Decide Which Drugs, Vaccines and Vapes Reach Americans Now Hold Permanent FDA Appointments

HHS named permanent directors for the FDA centers governing drugs, biologics, and tobacco after a year of turnover. What each office controls.

FDA gains ‘continuity’ as Mikhail, Davis named permanent CBER, CDER leaders

After almost two years of turnover in the FDA’s top ranks, the new appointments should help ease concerns about more turmoil ahead, one analyst said. 

FDA makes acting CDER, CBER chiefs permanent

Michael Davis becomes the permanent head of CDER, while Karim Mikhail is confirmed as permanent CBER director and the FDA names its first AI leader.

FDA’s Acting Drug, Vaccine Regulators Tapped for Permanent Roles

The Trump administration cemented the Food and Drug Administration’s senior leadership, naming officials in charge of regulating drugs, vaccines and tobacco, just weeks after White House aide Heidi Overton was nominated to take the agency’s top spot.

HHS Confirms Four Senior FDA Leaders, Including Agency's First-Ever AI Deputy Commissioner

HHS confirms permanent directors for CDER and CBER and creates FDA's first-ever Deputy Commissioner for Technology and AI.

HHS Names Jared Seehafer FDA's First AI Chief

This Jared Seehafer FDA AI chief appointment pairs with permanent leaders for CDER, CBER, and CTP.